Literature DB >> 32037942

American Academy of Clinical Neuropsychology consensus conference statement on uniform labeling of performance test scores.

Thomas J Guilmette1, Jerry J Sweet2, Nancy Hebben3,4, Deborah Koltai5, E Mark Mahone6, Brenda J Spiegler7, Kirk Stucky8,9, Michael Westerveld10.   

Abstract

Objectives: Descriptive labels of performance test scores are a critical component of communicating outcomes of neuropsychological and psychological evaluations. Yet, no universally accepted system exists for assigning qualitative descriptors to scores in specific ranges. In addition, the definition and use of the term "impairment" lacks specificity and consensus. Consequently, test score labels and the denotation of impairment are inconsistently applied by clinicians, creating confusion among consumers of neuropsychological services, including referral sources, trainees, colleagues, and the judicial system. To reduce this confusion, experts in clinical and forensic neuropsychological and psychological assessment convened in a consensus conference at the 2018 Annual Meeting of the American Academy of Clinical Neuropsychology (AACN). The goals of the consensus conference were to recommend (1) a system of qualitative labels to describe results from performance-based tests with normal and non-normal distributions and (2) a definition of impairment and its application in individual case determinations.
Results: The goals of the consensus conference were met resulting in specific recommendations for the application of uniform labels for performance tests and for the definition of impairment, which are described in this paper. In addition, included in this consensus statement is a description of the conference process and the rationales for these recommendations.Conclusions/Importance: This consensus conference is the first formal attempt by the professional neuropsychological community to make recommendations for uniform performance test score labels and to advance a consistent definition of impairment. Using uniform descriptors and terms will reduce confusion and enhance report comprehensibility by the consumers of our reports as well as our trainees and colleagues.

Keywords:  Impairment; performance tests; qualitative descriptors; test score labels

Year:  2020        PMID: 32037942     DOI: 10.1080/13854046.2020.1722244

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  21 in total

1.  Comparison of conventional and actuarial neuropsychological criteria for mild cognitive impairment in a clinical setting.

Authors:  Stephanie Fountain-Zaragoza; Sarah Ellen Braun; Michael David Horner; Andreana Benitez
Journal:  J Clin Exp Neuropsychol       Date:  2021-12-28       Impact factor: 2.475

2.  Examining racial disparities in the diagnosis of mild cognitive impairment.

Authors:  Andrew M Kiselica; Ellen Johnson; Kaleea R Lewis; Kate Trout
Journal:  Appl Neuropsychol Adult       Date:  2021-09-23       Impact factor: 2.248

3.  Neuropsychological functioning in children and adolescents with anti-NMDA receptor encephalitis (anti-NMDARE).

Authors:  Karine Hageboutros; Nina Hattiangadi Thomas; Melissa Hutchinson; Brenda Banwell; Katherine T Baum
Journal:  J Neurol       Date:  2022-09-16       Impact factor: 6.682

4.  Using multivariate base rates of low scores to understand early cognitive declines on the uniform data set 3.0 Neuropsychological Battery.

Authors:  Andrew M Kiselica; Troy A Webber; Jared F Benge
Journal:  Neuropsychology       Date:  2020-04-27       Impact factor: 3.295

5.  How impaired is too impaired? Exploring futile neuropsychological test patterns as a function of dementia severity and cognitive screening scores.

Authors:  Andrew M Kiselica; Ellen Johnson; Jared F Benge
Journal:  J Neuropsychol       Date:  2021-03-03       Impact factor: 2.864

6.  Robust demographically-adjusted normative data for the Montreal Cognitive Assessment (MoCA): Results from the systolic blood pressure intervention trial.

Authors:  Bonnie C Sachs; Gordon J Chelune; Stephen R Rapp; Ashley M Couto; James J Willard; Jeff D Williamson; Kaycee M Sink; Laura H Coker; Sarah A Gaussoin; Tanya R Gure; Alan J Lerner; Linda O Nichols; Carolyn H Still; Virginia G Wadley; Nicholas M Pajewski
Journal:  Clin Neuropsychol       Date:  2021-09-01       Impact factor: 3.535

7.  Mayo Normative Studies: Regression-Based Normative Data for the Auditory Verbal Learning Test for Ages 30-91 Years and the Importance of Adjusting for Sex.

Authors:  Nikki H Stricker; Teresa J Christianson; Emily S Lundt; Eva C Alden; Mary M Machulda; Julie A Fields; Walter K Kremers; Clifford R Jack; David S Knopman; Michelle M Mielke; Ronald C Petersen
Journal:  J Int Neuropsychol Soc       Date:  2020-08-20       Impact factor: 2.892

8.  Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.

Authors:  Andrew M Kiselica; Jared F Benge
Journal:  Dement Geriatr Cogn Disord       Date:  2021-06-29       Impact factor: 2.959

9.  The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression.

Authors:  Emma Rhodes; Philip S Insel; Meryl A Butters; Ruth Morin; David Bickford; Duygu Tosun; Devon Gessert; Howie J Rosen; Paul Aisen; Rema Raman; Susan Landau; Andrew Saykin; Arthur Toga; Clifford R Jack; Michael W Weiner; Craig Nelson; Scott Mackin
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Neurocognitive impairment, employment, and social status in radiotherapy-treated adult survivors of childhood brain tumors.

Authors:  Tiina M Remes; Emma Hovén; Niina Ritari; Heli Pohjasniemi; Riina Puosi; Pekka M Arikoski; Mikko O Arola; Päivi M Lähteenmäki; Tuula R I Lönnqvist; Marja K Ojaniemi; V Pekka Riikonen; Kirsti H Sirkiä; Satu Winqvist; Heikki M J Rantala; Marika Harila; Arja H Harila-Saari
Journal:  Neurooncol Pract       Date:  2021-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.